Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland ; volume:13 ; number:1 ; day:15 ; month:8 ; year:2022 ; pages:1-7 ; date:12.2022
Nature Communications ; 13, Heft 1 (15.8.2022), 1-7, 12.2022
- Urheber
-
Simpson, Colin
Kerr, Steven
Katikireddi, Srinivasa Vittal
McCowan, Colin
Ritchie, Lewis D.
Pan, Jiafeng
Stock, Sarah J.
Rudan, Igor
Tsang, Ruby S. M.
Lusignan, Simon de
Hobbs, F. D. Richard
Akbari, Ashley
Lyons, Ronan A.
Robertson, Chris
Sheikh, Aziz
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-32264-6
- URN
-
urn:nbn:de:101:1-2022110220442129359113
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Simpson, Colin
- Kerr, Steven
- Katikireddi, Srinivasa Vittal
- McCowan, Colin
- Ritchie, Lewis D.
- Pan, Jiafeng
- Stock, Sarah J.
- Rudan, Igor
- Tsang, Ruby S. M.
- Lusignan, Simon de
- Hobbs, F. D. Richard
- Akbari, Ashley
- Lyons, Ronan A.
- Robertson, Chris
- Sheikh, Aziz
- SpringerLink (Online service)
Ähnliche Objekte (12)
Blood coagulation disorders : hemorrhagic diatheses and thromboembolic diseases
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: a self-controlled case series analysis in Wales
Concurrence of immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura: a case report and review of the literature
Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials
Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS-CoV-2 infection: a self-controlled case series study
Hemostasis and hemorrhagic disorders
Current and Future Perspectives on ADAMTS13 and Thrombotic Thrombocytopenic Purpura
Thrombotic Microangiopathies, Thrombotic Thrombocytopenic Purpura, and ADAMTS-13
Dengue hemorrhagic fever as a rare cause of chronic immune thrombocytopenic purpura—a pediatric case report
Thrombotic Thrombocytopenic Purpura
Blood coagulation disorders : hemorrhagic diatheses and thromboembolic diseases
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: a self-controlled case series analysis in Wales
Concurrence of immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura: a case report and review of the literature
Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials
Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS-CoV-2 infection: a self-controlled case series study
Hemostasis and hemorrhagic disorders
Current and Future Perspectives on ADAMTS13 and Thrombotic Thrombocytopenic Purpura
Thrombotic Microangiopathies, Thrombotic Thrombocytopenic Purpura, and ADAMTS-13
Dengue hemorrhagic fever as a rare cause of chronic immune thrombocytopenic purpura—a pediatric case report
Thrombotic Thrombocytopenic Purpura
Blood coagulation disorders : hemorrhagic diatheses and thromboembolic diseases
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: a self-controlled case series analysis in Wales
Concurrence of immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura: a case report and review of the literature
Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials
Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS-CoV-2 infection: a self-controlled case series study
Hemostasis and hemorrhagic disorders
Current and Future Perspectives on ADAMTS13 and Thrombotic Thrombocytopenic Purpura
Thrombotic Microangiopathies, Thrombotic Thrombocytopenic Purpura, and ADAMTS-13
Dengue hemorrhagic fever as a rare cause of chronic immune thrombocytopenic purpura—a pediatric case report